Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Imatinib Mesylate in First-line CML
NCT02317159Phase 4Unknown
- Sponsor
- Chia Tai-Tianqing Pharmaceutical Group
- Start
- Feb 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of imatinib in chronic myeloid leukemia (CML), sponsored by Chia Tai-Tianqing Pharmaceutical Group. Status: unknown.
02
Drugs
03
Conditions
chronic myeloid leukemia (CML)
Beyond the preview
Go deeper on NCT02317159.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02317159.